Current Possibilities of In Vivo Proton (1H) Magnetic Resonance Spectroscopy in the Diagnosis of Brain Abscess
Authors:
Z. Večeřa 1; P. Hanzlíková 2; T. Krejčí 1; R. Lipina 1,3; M. Kanta 4
Authors‘ workplace:
Neurochirurgická klinika LF OU a FN Ostrava
1; MR pracoviště, Sagena s. r. o., Frýdek Místek
2; Lékařská fakulta OU v Ostravě
3; Neurochirurgická klinika LF UK a FN Hradec Králové
4
Published in:
Cesk Slov Neurol N 2016; 79/112(3): 294-298
Category:
Review Article
Overview
Brain abscess remains a serious inflammatory brain disease with significant morbidity and mortality. Neuroimaging is an essential part of diagnostic process, postcontrast T1-weighted imaging and diffusion-weighted imaging in particular. The examination should also include in vivo proton (1H) spectroscopy. Its role in differentiating similarly appearing intracranial cystic lesions was confirmed. Spectroscopy is increasingly being used in experimental and clinical applications – noninvasive identification of bacterial type, evaluation of chronological change of the brain abscess, assessment of therapy and postoperative changes. This paper summarizes current findings of in vivo proton MR spectroscopy in the diagnosis of cerebral abscess.
Key words:
brain abscess – diffusion weighted imaging – MR spectroscopy – diffusion tensor imaging
The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study.
The Editorial Board declares that the manuscript met the ICMJE “uniform requirements” for biomedical papers.
Sources
1. Alvis-Miranda H, Castellar-Leones SM, Elzain MA, et al. Brain abscess: current management. J NeurosciRural Pract 2013;4(Suppl 1):67– 81. doi: 10.4103/0976-3147.116472.
2. Starčuk Z, Krupa P, Starčuk Z jr, et al. 1H in vivoMR spektroskopie v klinické neurologii. Neurol Prax 2005;6(3):113– 39.
3. Oz G, Alger JR, Barker PB, et al. Clinical Proton MR Spectroscopy in Central Nervous System Disorders. Radiology 2014;270(3):658– 79. doi: 10.1148/radiol.13130531.
4. Demaerel P, Van Hecke P, Van Oostende S, et al. Bacterial metabolism shown by magnetic resonance spectroscopy. Lancet 1994;344(8931):1234– 5.
5. Hsu SH, Chou MC, Ko CW, et al. Proton MR spectroscopy in patients with pyogenic brain abscess: MR spectroscopic imaging versus single-voxel spectroscopy Eur J Radiol 2013;82(8):1299– 307. doi: 10.1016/j.ejrad.2013.01.032.
6. Otto D, Henning J, Ernst T. Human brain tumors: assess-ment with in vivo proton MR spectroscopy. Radiology 1993;186(3):745– 52.
7. Schumacher DJ, Nelson TR, Van Sonnenberg E,et al. Quantification of amino acids in human body fluids by 1 H magnetic resonance spectroscopy: a specific test for the identification of abscess. Invest Radiol 1992;27(12):999– 1004.
8. Harada M, Tanouchi M, Miyoshi H, et al. Brain abscess observed by localized proton magnetic resonance spectroscopy. Magn Reson Imaging 1994;12(8):1269– 74.
9. Garg M, Gupta RK, Husain N, et al. Brain abscesses: etiologic categorization with in vivo proton MR spectroscopy. Radiology 2004;230(2):519– 27.
10. Lai PH, Li KT, Hsu SS, et al. Pyogenic brain abscess: findings from in vivo 1.5-T and 11.7-T in vitro proton MR spectroscopy. AJNR Am J Neuroradiol 2005;26(2):279– 88.
11. Bajpai A, Prasad KN, Mishra P, et al. Multimodal approach for diagnosis of bacterial etiology in brain abscess. Magn Reson Imaging 2014;32(5):491– 6. doi: 10.1016/j.mri.2014.02.015.
12. Willett HP. Energy metabolism. In: Joklik WK, Willett HP, Amos DB, eds. Zinsser Microbiology, 19th ed. Stamford, CT: Appleton Lange 1988:25– 43.
13. Tsui EY, Chan JH, Cheung YK, et al. Evaluation of cerebral abscesses by diffusion-weighted MR imaging and MR spectroscopy. Comput Med Imaging Graph 2002;26(5):347– 51.
14. Himmelreich U, Accurso R, Malik R, et al. Identification of Staphylococcus aureus brain abscesses: rat and human studies with 1H MR spectroscopy. Radiology 2005;236(1):261– 70.
15. Jurtshuk P. Bacterial metabolism. In: Baron S, ed. Medical Microbiology, 2nd ed. Galveston, TX: University of Texas 1996:65– 84.
16. Britt RH, Engmann DR, Yeager AS. Neuropathological and computerized tomographic findings in experimental brain abscess. J Neurosurg 1981;55(4):590– 603.
17. Santy K, Nan P, Chantana Y, et al. The diagnosis of brain tuberculoma by (1)H-magnetic resonance spectroscopy. Eur J Pediatr 2011;170(3):379– 87. doi: 10.1007/s00431-011-1408-7.
18. Russell DG. Who puts the tubercle in tuberculosis? Nat Rev Microbiol 2007;5(1):39– 47.
19. Karakousis PC, Bishai WR, Dorman SE. Mycobacterium tuberculosis cell envelope lipids and the host immune response. Cell Microbiol 2004;6(2):105– 16.
20. Chang KH, Song IC, Kim SH, et al. In vivo single voxel proton MR spectroscopy in intracranial cystic masses. AJNR Am J Neuroradiol 1998;19(3):401– 5.
21. Grand S, Passaro G, Ziegler A, et al. Necrotic tumor versus brain abscess: importance of amino acids detected at 1H MR spectroscopy: initial results. Radiology 1999;213(3):785– 93.
22. Poptani H, Gupta RK, Jain VK, et al. Cystic intracranial mass lesions: possible role of in vivo MR spectroscopy in its differential diagnosis. Magn Reson Imaging 1995;13(7):1019– 29.
23. Peng J, Ouyang Y, Fang WD, et al. Differentiation of intracranial tuberculomas and high grade gliomas using proton MR spectroscopy and diffusion MR imaging. Eur J Radiol 2012; 81(12):4057– 63. doi: 10.1016/j.ejrad.2012.06.005.
24. Kaminogo M, Ishimaru H, Morikawa M, et al. Proton MR spectroscopy and diffusion-weighted MR imaging for the diagnosis of intracranial tuberculomas. Report of two cases. Neurol Res 2002;24(6):537– 43.
25. Mishra AM Gupta RK, Jaggi RS, et al. Role of diffusion-weighted imaging and in vivo proton magnetic resonance spectroscopy in the differential diagnosis of ring-enhancing intracranial cystic mass lesions. J Comput Assist Tomog 2004;28(4):540– 7.
26. Reddy JS, Mishra AM, Behari S, et al. The role of diffusion-weighted imaging in the differential diagnosis of intracranial cystic mass lesions: a report of 147 lesions. Surg Neurol 2006;66(3):246– 50.
27. Dusak A, Hakyemez B, Kocaeli H, et al. Magnetic Resonance Spectroscopy Findings of Pyogenic, Tuberculous and Cryptococcus Intracranial Abscesses. Neurochem Res 2012;37(2):233– 7. doi: 10.1007/s11064-011-0622-z.
28. Park SH, Chang KH, Song IC, et al. Diffusion weighted MRI in cystic or necrotic intracranial lesions. Neuroradiology 2000;42(10):716– 21.
29. Fuchs J, Siekmeyer M, Kiess W, et al. Tuberculous cerebellar abscess in a child--role of 1H-magnetic resonance spectroscopy. Klin Padiatr 2012;224(5):318– 9.
30. Chang L, Miller BL, McBride D, et al. Brain lesions in patients with AIDS: H1 MR spectroscopy. Radiology 1995;197(2):525– 31.
31. Barket et al. Clinical MR spectroscopy – techniques and applications. MRS in infectious, inflammatory, and demyelinating lesions, Cambridge University Press 2010: 110– 24.
32. Mamidi A, DeSimone JA, Pomerantz RJ. Central nervous system infections in individuals with HIV-1 infection. J Neurovirol 2002;8(3):158– 67.
33. Pomper MG, Constantinides CD, Barker PB, et al. Quantitative MR spectroscopic imaging of brain lesions in patients with AIDS: correlation with 11C-methyl-thymidine PET and thallium-201 SPECT. Acad Radiol 2002;9(4):398– 409.
34. Kingsley PB, Shah TC, Woldenberg R. Identification of diffuse and focal brain lesions by clinical magnetic resonance spectroscopy. NMR Biomed 2006;19(4):435– 62.
35. Simone IL, Federico F, Tortorella C, et al. Localized 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV. J Neurol Neurosurg Psychiatry 1998;64(4):516– 23.
36. Holtas S, Geijer B, Stromblad L, et al. A ring-enhancing metastasis with central high signal on diffusion--weighted imaging and low apparent diffusion coefficient. Neuroradiology 2000;42(11):824– 7.
37. Reiche W, Schuchardt V, Hagen T, et al. Differential diagnosis of intracranial ring enhancing cystic mass lesions – role of diffusion-weighted imaging (DWI) and diffusion-tensor imaging (DTI). Clin Neurol Neurosurg 2010;112(3):218– 25. doi: 10.1016/j.clineuro.2009.11.016.
38. Lai PH, Ho JT, Chen WL, et al. Brain abscess and necrotic brain tumors: discrimination with proton MR spectroscopy and diffusion-weighted imaging. Am J Neuroradiol 2002;23(8):1369– 77.
39. Herrnberger B. Diffusion tensor magnetic resonance imaging. Nervenheilkunde 2004;23:50– 9.
40. Gupta RK, Hasan KM, Mishra AM, et al. High fractional anisotropy in brain abscesses versus other cystic intracranial lesions. Am J Neuroradiol 2005;26(5):1107– 14.
41. Nath K, Agarwal M, Ramola M, et al. Role of diffusion tensor imaging matrics and in vivo proton magnetic resonance spectroscopy in the differential diagnsosis of cystic intracranial mass lesions. Magn Reson Imaging 2009;27(2):198– 206. doi: 10.1016/j.mri.2008.06.006.
42. Dev R, Gupta RK, Poptani H, et al. Role of in vivo proton magnetic resonance spectroscopy in the diagnosis and management of brain abscesses. Neurosurgery 1998;42(4):37– 43.
43. Pal D, Bhattacharyya A, Husain M, et al. In vivo proton MR spectroscopy evaluation of pyogenic brain abscesses: a report of 194 cases. AJNR Am J Neuroradiol 2010;31(2):360– 6. doi: 10.3174/ajnr.A1835.
44. Akutsu H, Matsumura A, Isobe T, et al. Chronological change of brain abscess in 1H magnetic resonance spectroscopy. Neuroradiology 2002;44(7):574– 8.
45. Burtscher IM, Holtas S. In vivo proton MR spectroscopy of untreated and treated brain abscesses. AJNR Am J Neuroradiol 1999;20(6):1049– 53.
46. Rémy C, Grand S, Lai ES, et al. 1H MRS of human brain abscess in vivo and in vitro. Magn Reson Med 1995;34(4):508– 14.
Labels
Paediatric neurology Neurosurgery NeurologyArticle was published in
Czech and Slovak Neurology and Neurosurgery
2016 Issue 3
Most read in this issue
- Sympathetic Chain Schwannoma – a Case Report
- Clinical Guideline for the Diagnostics and Treatment of Patients with Ischemic Stroke and Transitory Ischemic Attack – Version 2016
- Validity Study of the Boston Naming Test Czech Version
- Pre-motor and Non-motor Symptoms of Parkinson’s Disease – Taxonomy, Clinical Manifestation and Neuropathological Correlates